Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A strong case for personalized, targeted cancer prevention.

Cancer prevention research (Philadelphia, Pa.) - 1 Feb 2011

Dawson Marcia I

Abstract excerpt

The study reported by Lee and colleagues in this issue of the journal (beginning on page 185) incorporated global genetic variation within a new assessment of the outcome of a previously reported phase-III trial of low-dose 13-cis-retinoic acid (13-cRA) for preventing second primary tumors (SPT)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Head and Neck Neoplasms
Share to Neoplasm Recurrence, Local
Share to Neoplasms, Second Primary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Share to Precision Medicine

Share to Retinoid X Receptor alpha

Share to Survival Rate

Share to Treatment Outcome

Source

Identifiers

PMID: 21292632
DOI: 10.1158/1940-6207.CAPR-10-0386

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21292632-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

A strong case for personalized, targeted cancer prevention.PMID 21292632Read ↗

Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients.Semantic proximity Read ↗

Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention.Semantic proximity Read ↗

Cancer prevention: past challenges and future directionsSemantic proximity Read ↗

Multi-Omics Mendelian Randomization Integrating GWAS, eQTL, RNA-seq and Cell Line Experiment Reveal GLIPR1 and ARHGAP11A as Potential Targets of EGCG for Nasopharyngeal CarcinomaSemantic proximity Read ↗

Personalized medicine: will dentistry ride the wave or watch from the beach?Semantic proximity Read ↗

Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants.Semantic proximity Read ↗

Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: a Mendelian randomization studySemantic proximity Read ↗

Biomarker-Driven Personalized Immunoprevention: Toward More Efficient Clinical Trials?Semantic proximity Read ↗

Retinoid chemoprevention of aerodigestive cancer: From basic research to the clinicSemantic proximity Read ↗

[Chemoprevention of oral cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.